Valeo Financial Advisors, LLC Dexcom Inc Transaction History

Valeo Financial Advisors, LLC

$3.97 Billion
Q4 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 9,555 shares of DXCM stock, worth $821,634. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,555

Previous 10,041 4.84%

Holding current value

$821,634

Previous $672,000 10.57%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$65.68 - $81.01 $31,920 - $39,370	-486 Reduced 4.84%	9,555 $743,000
Q3 2024 Oct 10, 2024	BUY	$64.0 - $116.06 $155,136 - $281,329	2,424 Added 31.82%	10,041 $672,000
Q2 2024 Jul 10, 2024	BUY	$110.31 - $140.45 $227,459 - $289,607	2,062 Added 37.12%	7,617 $863,000
Q1 2024 Apr 25, 2024	BUY	$114.22 - $140.1 $87,606 - $107,456	767 Added 16.02%	5,555 $770,000
Q1 2024 Apr 19, 2024	BUY	$114.22 - $140.1 $6,967 - $8,546	61 Added 1.29%	4,788 $664,000
Q4 2023 Jan 29, 2024	BUY	$75.49 - $124.16 $178,382 - $293,390	2,363 Added 99.96%	4,727 $586,000
Q3 2023 Oct 19, 2023	BUY	$86.06 - $137.93 $62,049 - $99,447	721 Added 43.88%	2,364 $220,000
Q2 2023 Jul 14, 2023	BUY	$112.47 - $130.98 $184,788 - $215,200	1,643 New	1,643 $211,000
Q2 2021 Jul 22, 2021	SELL	$80.99 - $107.93 $6,155 - $8,202	-76 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$84.79 - $104.74 $2,034 - $2,513	-24 Reduced 24.0%	76 $27,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $1,482 - $1,985	19 Added 23.46%	100 $37,000
Q3 2020 Oct 28, 2020	SELL	$95.51 - $112.95 $7,163 - $8,471	-75 Reduced 48.08%	81 $33,000
Q2 2020 Jul 20, 2020	BUY	$62.68 - $105.34 $4,826 - $8,111	77 Added 97.47%	156 $63,000
Q1 2020 Apr 13, 2020	BUY	$47.79 - $75.63 $3,440 - $5,445	72 Added 1028.57%	79 $20,000
Q4 2019 Jan 24, 2020	SELL	$36.62 - $57.29 $915 - $1,432	-25 Reduced 78.13%	7 $2,000
Q3 2019 Oct 15, 2019	BUY	$35.53 - $43.8 $248 - $306	7 Added 28.0%	32 $5,000
Q2 2019 Jul 10, 2019	SELL	$27.84 - $38.92 $835 - $1,167	-30 Reduced 54.55%	25 $4,000
Q1 2019 Apr 12, 2019	BUY	$28.07 - $38.18 $1,543 - $2,099	55 New	55 $7,000
Q4 2018 Jan 30, 2019	SELL	$26.99 - $37.37 $539 - $747	-20 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $222 - $307	20	20 $1,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Dexcom Inc Transaction History